Icon PLC (ICLR)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$192.01
Buy
$212.10
$0.09 (+0.04%)
Prices updated at 12 Nov 2024, 22:35 EST
| Prices minimum 15 mins delay
Prices in USD
Icon PLC is a contract research organization that provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
---|---|
2023 | 29.56 |
2022 | 28.60 |
2021 | 27.52 |
2020 | 29.22 |
2019 | 29.64 |
2018 | 29.95 |
2017 | 41.58 |
2016 | 42.31 |
2015 | 42.29 |
Valuation data table
Year | Price / Sales |
---|---|
2024 | 2.12 |
2023 | 2.92 |
2022 | 2.09 |
2021 | 4.31 |
2020 | 3.78 |
2019 | 3.40 |
2018 | 2.99 |
2017 | 3.56 |
2016 | 2.59 |
2015 | 3.08 |
2014 | 2.21 |
Price/Forward earnings (YTD)
14.60
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
---|---|
2023 | 3.58 |
2022 | 2.92 |
2021 | 1.47 |
2020 | 10.34 |
2019 | 14.02 |
2018 | 14.34 |
2017 | 14.17 |
2016 | 14.80 |
2015 | 14.76 |
Debt profile data table
Year | Financial leverage |
---|---|
2023 | 1.84 |
2022 | 2.02 |
2021 | 2.16 |
2020 | 1.86 |
2019 | 1.80 |
2018 | 1.74 |
2017 | 1.80 |
2016 | 1.93 |
2015 | 2.25 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.